Orkla ASA (OTCMKTS:ORKLY) Reaches New 12-Month High - Is It Time to Buy?
Orkla ASA (OTCMKTS:ORKLY) recently achieved a new 52-week high during trading on Monday, reaching $11.08 at its peak, before settling at $11.04 with a trading volume of 19,072 shares. The stock had closed the previous day at $10.97.
Analysts Raise Price Targets
In a recent development, Sanford C. Bernstein upgraded their rating on Orkla ASA, elevating it from a "hold" to a "strong-buy" in a research report published on January 9th.
Orkla ASA Stock Performance
The company has a market capitalization of $11.01 billion, a price-to-earnings (PE) ratio standing at 19.71, and a beta of 0.53. Its 50-day moving average is priced at $9.76, while the 200-day moving average sits at $9.36. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.30, and a quick ratio of 0.70.
On February 13th, Orkla ASA reported its latest quarterly earnings, showing earnings per share (EPS) of $0.14 and total revenues of $1.70 billion. The company achieved a net margin of 8.58% and a return on equity of 13.13% during this period.
About Orkla ASA
Orkla ASA is engaged in the production of branded consumer goods, as well as in industrial and financial investment sectors. Their product lineup includes items such as frozen pizzas, ketchup, soups, sauces, bread topping, and ready-to-eat meals, which are sold through grocery stores, food service providers, convenience stores, and petrol stations.
Considerations for Potential Investors
If you're contemplating investing $1,000 in Orkla ASA, it’s essential to evaluate different factors. While the stock currently holds a strong buy rating from analysts, findings from MarketBeat indicate that there are five alternative stocks that analysts recommend as better investments at this time.
As market conditions can be unpredictable, investors may be seeking ways to mitigate risk. Having knowledge of beta and other financial indicators might provide insights for managing a personal investment portfolio.
Orkla, Stocks, Investment